15 research outputs found
A changing paradigm in heart transplantation: An integrative approach for invasive and non-invasive allograft rejection monitoring
Hepatocellular carcinoma conspicuity during arterial phase: comparison of contrast-enhanced 64-row multidetector CT with bolus tracking to MR imaging with bolus chase
Hepatocellular carcinoma conspicuity during arterial phase: comparison of contrast-enhanced 64-row multidetector CT with bolus tracking to MR imaging with bolus chase.
Hepatocellular carcinoma nodule conspicuity during arterial phase: comparison of contrast-enhanced 64-row multidetector CT with bolus tracking and MR imaging with bolus chase
Hepatocellular carcinoma nodule conspicuity during arterial phase: comparison of contrast-enhanced 64-row multidetector CT with bolus tracking and MR imaging with bolus chase.
The correct time window during the portal phase for liver metastasis detection on contrast-enhanced ultrasound.
Valore diagnostico dell\u2019enhancement a livello delle strie periviscerali nel constesto del tessuto adiposo mesorettale in pazienti affetti da carcinoma del retto dopo radio chemioterapia neoadiuvante
44\ub0 Congresso Nazionale della SIRM - Verona 11-15 giugno 201
A changing paradigm in heart transplantation: An integrative approach for invasive and non-invasive allograft rejection monitoring
Cardiac allograft rejection following heart transplantation is challenging to diagnose. Tissue biopsies are the gold standard in monitoring the different types of rejection. The last decade has seen an increased emphasis on identifying non-invasive methods to improve rejection diagnosis and overcome tissue biopsy invasiveness. Liquid biopsy, as an efficient non-invasive diagnostic and prognostic oncological monitoring tool, seems to be applicable in heart transplant follow-ups. Moreover, molecular techniques applied on blood can be translated to tissue samples to provide novel perspectives on tissue and reveal new diagnostic and prognostic biomarkers. This review aims to provide a comprehensive overview of the state-of-the-art of the new methodologies in cardiac allograft rejection monitoring and investigate the future perspectives on invasive and noninvasive rejection biomarkers identification. We reviewed literature from the most used scientific databases, such as PubMed, Google Scholar, and Scopus. We extracted 192 papers and, after a selection and exclusion process, we included in the review 81 papers. The described limitations notwithstanding, this review show how molecular biology techniques and omics science could be deployed complementarily to the histopathological rejection diagnosis on tissue biopsies, thus representing an integrated approach for heart transplant patients monitoring